Quantcast
Channel: Giving | Penn Medicine
Viewing all 85 articles
Browse latest View live

Reflecting on the Past: Alumni Headliners at Medical Alumni Weekend

$
0
0
Those who arrived early enough to enjoy Pancakes with Professors on Friday were also treated to a diverse and energetic telling of 50 years worth of medical tales courtesy of the Class of 1964 50th Reunion Panel.

50th Panel (l-r): Bob Fischer, M'64, FEL'70, Bill Eaton,
 C'59, M'64, GR'67, Martin Kanovsky, MD, John Forrest,
Jr., M'64 and Carl Bartecchi, M'64
Carl Bartecchi, M’64, author of A Doctor’s Vietnam Journal, was drafted as a flight surgeon soon after medical school. He spoke movingly of his annual volunteer efforts, begun in the late 1990s, of conducting critical care education programs in Hanoi and elsewhere in Vietnam.

Bob Fischer, M’64, FEL’70, who, as a preventive medicine officer, was also drafted to serve in Vietnam, is a professor of medicine and gastroenterologist at Temple University. He proudly offered a who’s who of gastroenterologists prominent locally and nationally who have strong ties to Penn Medicine.

Bill Eaton, C’59, M’64, GR’67, one of the first MD/PhD graduates at Penn and recognized at the Friday night Dean’s Dinner with a Distinguished Graduate Award for groundbreaking research during his lengthy NIH career, regaled the audience with tales of biophysical studies that have yielded major breakthroughs in understanding sickle cell disease.

John Forrest, Jr., M’64, who organized the panel discussion, is a professor of Medicine and director of the office of student research at Yale School of Medicine. He offered a slide show trip down memory lane, including reminiscences of influential faculty.

All of the distinguished panelists expressed pride in their association with Penn and the far-reaching impact of their medical educations here as well as amazement at the physical transformation of the campus.

Later that morning, Park Dietz, MD, MPH, PhD, FEL’78, recounted his unorthodox career path from medical student to expert witness in the nation’s highest-profile criminal cases. But even after decades of peering into criminal minds, from Jeffrey Dahmer to the Unabomber, Dietz hesitated to use the word "evil." Where others see evil, Dietz found “missed opportunities for prevention.” And he was equally skeptical of “sudden” acts of violence, seeing instead individuals who “throw out many signals of the trajectory they’re on” - and who can be stopped if we pay enough attention.


Acknowledging the formative impact of his mentor, Robert Sadoff, and Penn’s vibrant interdisciplinary atmosphere, Dietz traced the development of his innovative public-health approach to violence. His talk included some surprising details, from the orange squirt gun found in John Hinckley’s hotel room to a peculiar fact about stalkers (hint: beware a love letter more than a death threat). But Dietz’s most intriguing revelation was also the most fundamental. Our best chance for deterring violence, he concluded, is to intervene in a manner that communicates respect for the “essential humanity” of troubled individuals.

Faculty Stars Highlight Breakthroughs Paving the Way for Personalized Medicine

$
0
0
This Medical Alumni Weekend, Glen Gaulton, PhD, HOM’91, moderated a panel of our leading faculty who are finding success in translating basic science findings into tangible advances in patient care.

Ralph Muller, CEO of the health system, introduced the panel, noting “All of us in the clinical enterprise are deeply aware that our leadership in science underlies our excellence in patient care.”

Dr. Gaulton, the Executive Vice Dean and Chief Scientific Officer of the Perelman School, oversees the academic component of all research and research education, including the Combined Degree Program, Biomedical Graduate Studies, and Masters and Postdoctoral Programs. He has been a great leader in driving basic science and translational research across Penn Medicine.

Drs. Gilliland, Drebin, Litt, and Zaret covered the state of pancreatic cancer, epigenetic, and bioengineering research at Penn, focusing specifically on progress in the treatment of pancreatic cancer and epilepsy and the collaborative efforts among faculty that facilitate discovery.

Panel (l-r) with Gary Gilliland, MD, PhD,
Jeff Drebin, MD, PhD, Brian Litt, MD, Ken Zaret,
PhD, and Glen Gaulton, PhD, HOM'91
Gary Gilliland, MD, PhD, inaugural Vice Dean and Vice President for Precision Medicine, praised Penn’s foresight in its emphasis on collaborative efforts to implement individualized medicine. He cited some of the work of his fellow panelists Drs. Drebin and Zaret as an example. An internationally renowned oncology investigator, Dr. Gilliland previously served as Senior Vice President of Merck Research Laboratories and Oncology Franchise Head, as well as professor of medicine and professor of stem cell and regenerative biology at Harvard Medical School.

Jeff Drebin, MD,PhD, Chair of the Department of Surgery and the 14th John Rhea Barton Professor of Surgery, discussed his role as co-principal investigator on the $22 million dollar clinical and translational “dream team” award from the Stand Up to Cancer Foundation for innovative studies in pancreatic cancer. His research, which has contributed significant insight into the genetic causes of cancer, has also been informed by the work of panelist Ken Zaret, PhD, the Joseph Leidy Professor in the Department of Cell and Developmental Biology. Dr. Zaret's discoveries, as Associate Director of the Institute for Regenerative Medicine and Director of that Institute’s Program in Cellular Reprogramming and Epigenetics, are being used to develop liver and pancreas cells from stem cells for regenerative medicine.

Brian Litt, MD, Professor of Neurology and Professor of Bioengineering, and Director of the Epilepsy Monitoring Unit, offered a window into futuristic medicine happening now. His lab is developing devices made with flexible silicon filaments that essentially melt into place, snugly embedding in the surface of the brain or heart to achieve unprecedented accuracy in recording activity. Dr. Litt focuses primarily on the use of such devices in epilepsy treatment.

Words from the Heart: Graduation 2014

$
0
0
This year’s Perelman School of Medicine graduation left no doubt -- medicine inspires the strong of heart.

Dean J. Larry Jameson, MD, PhD
Dean J. Larry Jameson, MD, PhD, congratulated the graduates and welcomed the faculty, family, alumni, and trustees filling Verizon Hall to the occasion that “makes tangible all your hard work,” and officially marks the transition from student to physician.

For several trustees on stage, the day was particularly meaningful. Raymond H. Welsh, W’53, witnessed his granddaughter, Christina, receive her degree; Raymond G. Perelman, W’40, HON’14, attended on the eve of receiving his own honorary Doctor of Laws degree, and Walter J. Gamble, M’57, as is his custom, personally congratulated the latest class of Gamble Scholars.

The Dean noted that with alumni looking back on 50 years in practice, joined by students just setting out on careers, graduation brings 100 years of medicine into view. He commented that while technology and demographics have changed (this year’s class is about half men and women), the primacy of the physician-patient relationship endures. He called on students to keep the passion and altruism that brought them to medicine as they set out to “make the world a healthier and more equitable place.”

Elizabeth G. Nabel, MD
President of Harvard-affiliated Brigham and Women’s Hospital, Elizabeth G. Nabel, MD, offered the day’s first address. Around the time of her own graduation, Dr. Nabel cared for a young woman in a Boston ER, sending her home after tests ruled out any reason to keep her. Two days later, the patient returned with a full blown heart attack. She recovered, and gave Dr. Nabel a glimpse she never forgot of a “hidden story waiting to be told.”

Years later, as director of the National Heart, Lung, and Blood Institute, Dr. Nabel launched the Red Dress Heart Truth campaign. Joining forces with First Lady Laura Bush, Diet Coke, and, through the Red Dress Fashion Show, celebrities and fashion designers, this advocacy effort set out to change the way patients, physicians, and the public think about heart disease.

“Look deep with yourself,”Dr. Nabel said. This era of “change in overdrive” will bring “opportunities for advocacy and action.”

“Keeping your patients first,” she concluded, “will lead you to the life of integrity embodied in the Hippocratic oath.”

Arlene Parsons Bennett, ED'60, M'64
The 50th year class was represented by Arlene Parsons Bennett, ED’60, M’64, the first African-American woman to graduate from the School.

Dr. Bennett was born at Women’s Hospital in West Philadelphia, where she received her early medical care. “Until I was nine or ten,” she said, “I thought most doctors were women.”

Dr. Helen Dickens and Dr. Mary Dickens Varker stand out in her memory, and early on she decided to become a physician.

After three years in the United States Air Force Dr. Bennett was able to attend Penn. One of only 9 women in her medical school class, she reported that her “male classmates were very protective - they still are.”

She worked in general pediatrics for the next 10 years.

“By then,” she said, “I had had quite enough of treating parents on the side. I decided that treating them directly would be a more effective approach. So I did a residency in psychiatry.”

She has been an active staff psychiatrist at Pennsylvania Hospital since 1980, and a Clinical Associate at HUP since 1977.

“I love every minute of my work, even at 80 years old,” she said.

She advised students, “Your heart and mind must be engaged for you to truly be a great doctor,” and challenged the graduates to report back in 50 years on how they have enhanced medicine.

Distinguished Graduate Awards Presented

$
0
0

Congratulations to this year's winners: William A. Eaton, C'59, M'64, GRM'67 and Alan J. Wein, M'66, INT'70.

The Distinguished Graduate Award honors highly accomplished alumni for their outstanding service to society and to the profession of medicine and for their notable accomplishments in biomedical research, clinical practice, or medical education. Previous recipients include Nobel laureates Michael S. Brown, C'62, M'66, HON'86 and Stanley B. Prusiner, C'64, M'68, and former Surgeon General C. Everett Koop, GRM'47, HON'90.

 A brief description of their recent accomplishments follows:

William A. Eaton, MD, PhD, receiving Award from Dean J. Larry Jameson MD, PhD
William A. Eaton, MD, PhD, is Chief of the Laboratory of Chemical Physics at the National Institute of Diabetes and Digestive and Kidney Diseases, and Chief of the Biophysical Chemistry Section at NIH. He serves as a member of the American Academy of Arts and Sciences and the National Academy of Sciences. He has received numerous awards, including the Meritorious Service Medal of the United States Public Health Service.


Alan J. Wein, MD, PhD, receiving Award from Dean J Larry Jameson, MD, PhD
Alan J. Wein, MD, PhD, is Founders Professor and Chief of the Division of Urology at the Perelman School of Medicine, and Chief of Urology and Director of the Urology Residency Program at the Hospital of the University of Pennsylvania. He is the editor-in-chief of Campbell-Walsh Urology, the textbook considered to be the gold standard in urology.

Visit Medical Alumni web site for more details of their contributions.

 

MVP: Gift of William Bates, Jr., Supports Young Scientists, Advances Alzheimer’s Research, and Connects to Family Heritage

$
0
0
By giving to the Center for Neurodegenerative Disease Research (CNDR), William Bates, Jr., has become one of Penn Medicine’s Most Versatile Players. Among his gift’s many roles: A tribute to his wife of 61 years, Elizabeth, who died from Alzheimer’s disease. A contribution to a cure. A strike against the escalating crisis in research funding for young scientists. And, more unexpectedly, a renewal of his lifelong connection to Penn.

In 2008, Mr. Bates established the Bates Family Travel Fellowship, an endowed fund supporting postdoctoral fellows at the CNDR. Conference attendance is a professional necessity for these young scholars, but often they cannot afford the associated expenses. This award enables recipients to travel and attend meetings with top scientists from around the world, fostering the intellectual collaboration needed to advance a cure.

Given decreased federal dollars for science, gifts like this are more crucial than ever. Currently, the National Institutes of Health (NIH) can fund just half of viable proposals, leaving many promising ideas – and careers – unrealized.

“We have a serious risk of losing the most important resource that we have, which is this brain trust, the talent and the creative energies of this generation of scientists,” said NIH director Francis Collins.

As home to the largest Biomedical Graduate Studies program in the nation, Penn educates the researchers who will meet the biggest scientific challenges of the coming decades, including the urgent search for an Alzheimer’s cure. Today, five million Americans suffer from the disease; by 2050, that number is projected to grow to 14 million.

Federal cutbacks mean that further progress depends increasingly on the philanthropy of friends like Mr. Bates, who takes the mission of Penn’s young scientists seriously – and very personally. “I don’t think anything would please me more than to see a breakthrough in my lifetime,” he said.

William Bates, Sr., chief surgeon at both
Graduate Hospital and Penn Presbyterian
For Mr. Bates, a personal connection to Penn Medicine is nearly a birthright. His father, William, earned both his undergraduate and medical degrees from Penn; his mother, her nursing degree. During World War I, his parents were part of a Penn initiative to establish wartime medical facilities in France. After the war, Dr. Bates set up his medical practice in Philadelphia, eventually becoming chief surgeon at both Graduate Hospital and Penn Presbyterian. Mr. Bates vividly recalls the telephone – “always ringing” – next to his father’s seat at the dinner table.

Mr. Bates’s 45-year career in banking was highlighted by his becoming vice chairman of the Philadelphia National Bank (now Wells Fargo) and at the same time serving a term as chairman of the board of VISA, the credit card organization. He “retired” at 65, only to launch Consumer Loan Services, a first-of-its-kind consulting firm serving small lenders. Within five years, the company grew from a single room furnished with a folding table and chairs to a 200-employee operation.

But his well-earned retirement was overshadowed by his wife’s Alzheimer’s diagnosis. After her death in 2006, the memory of her suffering “became an overwhelming desire to try to do some good.” This desire is shared by Mr. Bates’s two sons, William and Jeffrey, who have pledged to continue support for the CNDR past his lifetime.

For Mr. Bates, philanthropy has yielded new connections to Penn. Over the years he has met with CNDR directors Drs. Virginia Lee and John Trojanowski and the recipients of the travel award. “I get so much pleasure from seeing these young people at the beginning of their careers, with all of it ahead of them,” he said.

Supporting Penn’s next generation of scientists also led Mr. Bates to recover a little piece of his own history. With the help of Penn Medicine’s development staff, he located a portrait of his father that once hung in the lobby of Graduate Hospital. Today, the portrait resides in his home. At 92, Mr. Bates has an extraordinary connection to Penn’s past. But the CNDR’s search for an Alzheimer’s cure keeps him looking to the future. “I hope I’m still here when this puzzle is solved,” he said. “It would be the most wonderful gift I could have.”

To learn more about how to support the Institute on Aging contact Michael Sofolarides, director of development at Penn Medicine, at 215.573.0187 or msof@upenn.edu.

CurePSP and Penn Launch 2014 Challenge to Fund Immunotherapy for Neurodegenerative Disease

$
0
0

Contributions needed to reach $1 million goal

CurePSP has committed $600,000 to Penn’s Center for Neurodegenerative Disease Research (CNDR) – and promised to join with Penn to raise up to $400,000 more in 2014.

“For years our focus was simply to understand this constellation of related disorders,” said CNDR director Virginia Lee, PhD, MBA. “Now we have the information to make therapeutic breakthroughs a real, even imminent, possibility.”

Dr. Lee and John Trojanowski, MD, PhD, director of Penn’s Institute on Aging, are counted among the world’s most influential neurodegenerative disease researchers. The duo made the pivotal discovery that the “tangles” in Alzheimer’s brains contain the protein tau.

Now, their research suggests that stimulating the body’s own immune cells could eliminate this abnormal protein, which is present in many related diseases including Alzheimer’s, Parkinson’s, and progressive supranuclear palsy (PSP).

CurePSP awarded the CNDR the Special Initiatives Grant because the foundation judged Penn’s research to be the most promising new development in the field. CurePSP is dedicated to advancing research, education, and patient advocacy for PSP and related neurodegenerative diseases.

Patricia Richardson and her father.
Today there are no treatments for PSP. Actress Patricia Richardson lost her father to PSP in 2005, and has become a spokesperson for CurePSP. She recalled that when the disease left him practically immobile, he used a thumbs-up – a familiar gesture from his days as a Navy test pilot – to communicate with family.

“I can’t tell you what a loss it was when Dad could no longer give his trademark thumbs-up,” Richardson said. “He was just trapped in the prison his body had become.”

Private support is essential to funding innovative studies like these, which are not eligible for government dollars before the clinical stage. CurePSP’s partnership, with the support of generous donors, makes it possible for the CNDR’s discoveries to become therapeutic advances – not just missed opportunities.

Drs. Lee and Trojanowski will speak at the Penn Club in New York, NY, on Tuesday, September 9, 7:00 – 9:00 pm. To learn more about this event, and how to support the CurePSP challenge, contact Michael Sofolarides, director of development at Penn Medicine, at 215.573.0187 or msof@upenn.edu.

Take a Step Forward in the Fight Against Alzheimer’s Disease

$
0
0

Join Penn’s 5K for the IOA and Memory Mile Walk

This fall, get outdoors to exercise with family and friends, enjoy prizes and giveaways, and view the Philadelphia skyline – all while supporting Alzheimer’s research and care at Penn’s Institute on Aging (IOA).

Open to individuals and teams, the third annual 5K for the IOA kicks off at 8 am on Sunday, September 21, in Penn Park. The Memory Mile Walk (approximately 1.5 miles) begins at 8:10. Runners and walkers will meet at the Shoemaker Green entrance, on 33rd between Walnut and South.

Proceeds go to the IOA’s Pilot Grant Program, which promotes innovative research for Alzheimer’s and other neurodegenerative diseases. Participants have the option to create a personalized online giving page that invites friends to support their run and raise vital research dollars for the IOA.

Every participant receives a gift bag with a t-shirt and valuable coupons. Prizes include a $100 Doc Magrogan’s gift card for the fastest team, and $75, $50, and $25 Philadelphia Runner gift cards for the top three men and women. Medals will be awarded to the first-place individuals in each age group.

Sign up, volunteer, or donate here. The registration fee is $25 ($30 after September 7) or $20 with a Penn Student ID. Walk-up registration is available on race day – and parking is free!

Questions? Contact Mary Tong, associate director of development at Penn Medicine, at 215-746-2204 or tongm@upenn.edu.

Rare "Incision-less" Brain Surgery a Specialty at Pennsylvania Hospital

$
0
0
When 28 year-old Jonathon was too tired to go shopping with his wife, he had no idea what was about to follow. The Reading native had only been married for four months and all was going well. But that day, his arm suddenly cramped, he collapsed, and began having seizures. He was taken to Reading Hospital, where tests revealed an epidermoid cyst in his brain that was creating pressure and triggering the seizures.

Upon seeing that the tumor was in a challenging location, physicians in Reading recommended Pennsylvania Hospital neurosurgeon John Y.K. Lee, MD, medical director of the Penn Gamma Knife Center and assistant professor of Neurosurgery at the Perelman School of Medicine.
 
Dr. Lee is one of the few physicians in the country who specialize in removing brain tumors in difficult-to-access areas without performing a standard craniotomy. Instead, he operates via an "incision-less" brain technique using 3-D endoscopic techniques. His microscopic, minimally invasive techniques, offer patients like Jonathan less invasive treatment options with a shorter recovery time than traditional brain surgeries.
 
In partnership with Jason Newman, MD, director, Head & Neck Surgery at PAH and assistant professor of Otorhinolaryngology: Head and Neck Surgery, Dr. Lee removed the benign brain tumor without cutting open Jonathan's skull.
 
The surgery took eight hours, in large part, because they used a rare, less-invasive approach through Jonathan's nose in order to preserve most of his sense of smell.
 
Jonathan recovered successfully and does not have any permanent scars from the procedure. His story was featured on 6ABC's  "Action News." To watch the segment and see Dr. Lee demonstrate the procedure, click here.
 
The research and training that goes into providing this level of advanced health care is supported by Friends like you. To learn more about Dr. Lee and his work, please contact Sarah Evans at (215) 746-3005, or saraheva@upenn.edu.

22 Outstanding Students Receive Donor-Funded Prizes at 2014 Graduation

$
0
0

This year, more students than ever received recognition and a financial token of appreciation through awards created by alumni, alumni families, and friends of the Perelman School of Medicine. Congratulations to our students for their achievements in academics, research, and patient care, and thank you to the generous donor families who made these honors possible. 


The 2014 Prizes and Winners

Nancy C. Bell, MD Memorial Prize in Dermatology: John Samuel Barbieri

Emily and Francis Botelho Prize for Excellence in Basic Science: Shaan Syed Khurshid

Sarle H. Cohen Award for Geriatric Medicine: Nina Wanning Zhao

James B. Couch, M’81 Prize: Alexander Li-Che Chin

Gertrude M. and Ezra M. Eisen Prize: Shaan Syed Khurshid

Jesse H. Frank, MD Prize in Pathology: Ellen Miriam Fraint

Theodore Friedmann Prize: Andrew Robert Fisher

Byron S. Hurwitz, MD, M’66 Memorial Prize: Keirnan Lovewell Willett

Peter H. Hutchinson, MD, M’06 and Rebecca N. Hutchinson, MD, M’06 Prize: Joseph John Ruzbarsky

Rose and Hershel Kanovsky Prize in Internal Medicine: Maria Ciocca Basil

Herbert and Faye Moskowitz Prize: Catherine Louise Auriemma and Austin Srinivas Kilaru

William G. Munns Memorial Prize: Daniel Caldwell Austin

The Gary M. Phillips, MD, C’87, WG’91, M’92, RES’97 and Helen Apostolou Phillips, C’87 Prize: Michael Elias Abboud

Dr. I. S. Ravdin Prize: Elizabeth Marie Sonnenberg

The David S. Seller, MD, M’22 and Robert H. Seller, MD, M’56 Prize for Excellence in Primary Care Diagnosis: Shaan Syed Khurshid

Dr. Ramon Sifre Prize for Excellence in Diagnostic Medicine: Austin Srinivas Kilaru

Russell J. Stumacher, MD Memorial Prize: Lauren Emily McCollum

Robert Suskind, C'59, M'63 and Leslie Lewinter-Suskind Prize in Global Health: Julie Anne Caplow

The J. George Teplick MD FACR Memorial Award: Dania Daye

Nikitas J. Zervanos, MD Prize in Family Medicine: Nathalie Claire Boittin and Lori A. Atkinson

Partners In Hope - Susan and Jeffrey Levitt

$
0
0
“Meeting the doctors and scientists focused on solving the mysteries of cancer has been incredibly inspiring and humbling. My wife and I are already proud Penn alumna, and couldn’t be more pleased to support the university that we both love, and the important work at Penn’s Abramson Cancer Center that has the potential to change the world.” – Jeff Levitt, W’71, Partner in Hope, Chairman and Founder of Precyse Solutions, LLC

In October 2011, Jeff Levitt came to the Abramson Cancer Center to participate in a very special Abundant Treasures and Miraculous Discoveries: Solving the Mysteries of Cancer. Jeff is a member of the Philadelphia chapter of the World Presidents’ Organization (WPO) who partners each year with Penn Medicine to host a program highlighting innovative research and care initiatives. With deep connections to Penn and cancer, it was no mystery that Jeff would find himself attending this program. Jeff and his wife Susan Mazer Levitt attended Penn, both graduating in the Class of 1971, continuing a tradition set by Susan’s father. Their daughter, Kate, is also a proud Penn alumna of the Class of 2002. And Jeff is the Chairman and Founder of Precyse Solutions LLC, a company that is involved amongst other things with the gathering and abstracting of clinical data for cancer programs across the country.


Jeff was impressed with the passion and vision of top scientific and clinical faculty as they shared their advances in novel treatments for breast, melanoma, lung, and pancreatic cancers – never shying away from challenging diseases. He knew right away that he wanted to help support their efforts and after hearing from Dr. David Roth, Chair of Penn’s new Center for Personalized Diagnostics (CPD), he settled on a project to be part of.

“Personalized medicine is today’s science,” says Roth. “Every day I come to work thinking that today might be the day that we discover the genetic breakthrough we’re looking for to cure cancer. Philanthropy helps drive forward our discoveries at an even faster pace, and gives us the resources to explore so many different promising areas of personalized, effective cancer care.” With the help of Dr. Roth and others, Penn has the infrastructure to analyze cancer patients’ tumor for the gene, protein or molecule that makes it different. It is the gathering of this information that will allow doctors to understand fully what will help one patient versus another, improving not only outcomes, but also quality of life. For Penn Medicine it’s PERSONAL!

For the Levitt’s, it’s personal too! Jeff and Susan decided to give both their money and their time to help make a difference at the Abramson Cancer Center. As members of the Abramson Cancer Center Director’s Leadership Council, they are active volunteers and advocates. “We support a multitude of worthy organizations, but it’s been particularly fulfilling to give to Abramson,” shares Susan. Jeff continues, “It’s hard to calculate our return on investment for being part of an institution making such a profound difference in Philadelphia, especially when we read the stories of hope that they provide to so many people suffering from cancer in Philadelphia and around the world."

To make a gift, click here, or contact Evelyn Schwartz at evelynsz@upenn.edu or (215) 898-8625.

Back in the Saddle with Team Penn Vet for the Ride to Conquer Cancer

$
0
0
Ride to Conquer Cancer Philadelphia
When we think of cancer, we don’t always think of cancer in animals. But, for Sarah Rauers, administrative assistant, for the animal biology department at the University of Pennsylvania School of Veterinary Medicine, cancer in animals – and people – is always in her thoughts.

“At this point, I don’t think there is anyone who doesn’t know someone with, or who has had cancer,” says Sarah. “I’ve had family members, as well as pets, I’ve watched suffer through the disease.”

And that, says Sarah, is one of the things that has motivated her to join the Philadelphia Ride to Conquer Cancer this October.

“I went to an information session with my co-workers, and we decided to start a team together,” says Sarah. “There was so much energy and hope we saw within the ride and the research happening at Penn, we wanted to support the cause.”

Cancer Research at Penn Vet

Within the faculty at Penn Vet, there is a lot of research that focuses on cancer. “Penn Vet studies cancer biology in mice, dogs and larger animals – all part of a mission to pursue translational medicine,” says Sarah. “Breakthroughs in cancer research today made in research could someday can one day help conquer cancer in all species.”

The other motivation behind Sarah’s decision was a very personal one.

"A couple of years ago I was hit by a car while commuting on my bike to work,” she says. “I suffered a great deal of physical and emotional trauma from that experience. Getting back on my bike and participating in The Ride is a big milestone for me.”

As for her fundraising efforts, Sarah has been pleasantly surprised at the support she’s gotten from family and friends.

“Fundraising has been so much easier than I thought it would be. Shocked by the generosity of my friends and family, and ‘Facebook friends,’” she says. “If you are considering joining, just do it. For about three days after my team signed up we were concerned about what we got ourselves into but it’s going to be easier and more rewarding than any of us think!”

Check out more from Team Penn Vet here.

The Ride to Conquer Cancer®

Join Penn Medicine’s Abramson Cancer Center (ACC) on October 11 to 12, 2014 in the Ride to Conquer Cancer (RTCC)—an unforgettable and epic bike ride through Pennsylvania’s picturesque landscape -towards one life-changing destination: to cure cancer. The ride isn't just for cyclists, it's for anyone who wants to see a cure for cancer.

At two-days and 150+ miles the RTCC will be a physical challenge—and an emotional and inspirational weekend—that will give you a chance to ride side by side with physicians, patients and families--raising serious funds and awareness in the ACC’s fight to cure cancer.

The funds raised through the ride will be put to use immediately, powering the ACC's vision to eradicate cancer as a cause of human disease and suffering through precision medicine, novel research, next-generation therapies, and compassionate care.

Join Today

This event will be remarkable, bringing together communities of cancer survivors, cyclists, and their supporters with a common goal to conquer this disease. Join the ride in October by registering today at www.ridetovictory.org or by calling (844) 777-7433.

Before the ride, you will have access to:
  • Expert coaching
  • Training rides in your area
  • Personal web page for fundraising
  • Helpful manual
  • 2014 ride commemorative item
During the ride, participants will have access to:
  • Event-day ride jersey
  • Support along the route
  • Catered meals
  • Entertainment at camp
  • Massage and medical care

The Little Team for a Cure - Tasha's Ride to Conquer Cancer Story

$
0
0
Ride to Conquer Cancer Philadelphia
The LITTLE Team for a CURE. From left: Patrick Heringslack, Tasha Little, Howard Little.
"We're all living one life, we're all fighting to live. I feel it matters. I feel I need to contribute however I can. I was lucky and I have a will to live."– Tasha

Tasha Little was 42 years old when she learned she had breast cancer. She had no family history of breast cancer, exercised regularly, maintained a healthy diet, and was active with her two boys. But, she still found herself facing a cancer diagnosis.

“I’ve always believed in preventative care,” says Tasha. “When I learned the lump that showed up on a routine mammogram was breast cancer, I was completely overwhelmed.”

At the time she was diagnosed, she had just gone through a divorce, and found out she had cancer while moving from her home of 13 years following the split.

Fortunately, Tasha had time to research her options. She decided to get her cancer treatment at the Abramson Cancer Center.

“Getting the cancer out of my body was obviously important to me,” she says, “but so was reconstruction. When I met Drs. Tchou and Wu, I knew I was in the right place.”

Tasha was impressed with the way both the surgical oncologist and plastic surgeon collaborated as a team.

“My surgeons had a wonderful relationship with each other, and it made me feel comfortable to know they worked together so well,” she says.

Tasha had unilateral mastectomy (removal of one breast) and reconstruction at Penn. That was just over a year ago, and today, she’s giving back by participating in the inaugural Philadelphia Ride to Conquer Cancer® that benefits the Abramson Cancer Center.

“I heard the radio ads, and since I was an avid cyclist before I was diagnosed, I thought it would be a great way for me to get back in the saddle for a good cause,” says Tasha.

Tasha invited her dad, Howard, and her friend Patrick to join her on the ride. Riding with her dad has been a special experience, because her family had a big part in her recovery.

“I was raising two boys. My mother would take me to the hospital while my dad stayed at home and took care of the boys,” says Tasha. “This whole experience was a family effort, even though it was something I personally dealt with.”

"Parents who know what it is like to have a sick child know that no words can comfort the fear and anxiety and emotions you experience as a parent,” says Howard. “Even with a child in her 40s, it still feels like she’s your little baby and you just want to comfort and protect her. You have to have hope and positivity and know that doctors are doing as much as they can for you."

So far, “The LITTLE Team for a CURE has raised $4,811.00 and plans to meet their goal of $8,000.00 in time for the ride. "If you're an avid rider, it's about what you can do to help. If you've never rode before, it can be done. People are generous and if you're passionate people will support you,” says Tasha.

The Ride to Conquer Cancer®

Join Penn Medicine’s Abramson Cancer Center (ACC) on October 11 to 12, 2014 in the Ride to Conquer Cancer (RTCC)—an unforgettable and epic bike ride through Pennsylvania’s picturesque landscape -towards one life-changing destination: to cure cancer. The ride isn't just for cyclists, it's for anyone who wants to see a cure for cancer.

At two-days and 150+ miles the RTCC will be a physical challenge—and an emotional and inspirational weekend—that will give you a chance to ride side by side with physicians, patients and families--raising serious funds and awareness in the ACC’s fight to cure cancer.

The funds raised through the ride will be put to use immediately, powering the ACC's vision to eradicate cancer as a cause of human disease and suffering through precision medicine, novel research, next-generation therapies, and compassionate care.

Join Today

This event will be remarkable, bringing together communities of cancer survivors, cyclists, and their supporters with a common goal to conquer this disease. Join the ride in October by registering today at www.ridetovictory.org or by calling (844) 777-7433.

Before the ride, you will have access to:
  • Expert coaching
  • Training rides in your area
  • Personal web page for fundraising
  • Helpful manual
  • 2014 ride commemorative item
During the ride, participants will have access to:
  • Event-day ride jersey
  • Support along the route
  • Catered meals
  • Entertainment at camp
  • Massage and medical care

Ride To Conquer Cancer - Jim's Story, and His Tips for New Riders

$
0
0

As a competitive cyclist in the 70s, Jim Finkel rode alongside some of the best cyclists in the world. He didn’t know it at the time, but his constant challenges to go faster, work harder, go longer distances, and fuel his body with proper nutrition got him in shape for the greatest challenge of his life – cancer.

And, in a way, cycling saved his life.

“Towards the end of 2012 I was having trouble breathing, either on or off the bike,” says the 61-year-old mechanical engineer. “I was unable to clear my nostrils as I rode, and when over-the-counter medications and antibiotics didn’t work, we knew it was time to take the next step toward a proper diagnosis.”

After scopes and scans revealed a tumor in his nasal cavity, Jim began an 18-month journey to treat cancer that involved two surgeries, and radiation therapy. But he barely took a break from his bike. 

“When it was warm enough to ride outside, I immediately started to kick up my mileage while not pushing too hard,” says Jim. “Once I’d started radiation therapy, I was back up to doing at least four hours a week of saddle time on a bike.”

“Keeping my weight up during treatment was a challenge, but cycling actually helped. Though my sense of taste was dulled, I was used to getting calories back in to my body. I knew I had to eat and carefully match my calories in to calories burned, so I held weight throughout the process.”

Jim has joined the Abramson Cancer Center’s Ride to Conquer Cancer, a 150-mile ride that benefits cancer research at the Abramson Cancer Center. 

“I can’t say enough about the Abramson Cancer Center,” says Jim. “My surgeon Dr. O’Malley, my oncologist, Dr. Chip Staddon at Penn Medicine at Radnor, and Dr. Geoffrey Geiger at both the Valley Forge and the Perelman Center for Advanced Medicine always put me as a person in front of me as a patient. I want my story to give others hope.”

You don’t have to be a competitive cyclist to join the ride, however. In fact, Jim shares these tips for those people riding the event who may not be seasoned cyclists.


  1. Get slick tires: Even if you are riding a mountain bike, swapping out the heavy tread for slick, thinner tires will help you maintain speed with less effort.
  2. Inflate your tires to their recommended levels: Again, this will be less work to ride.
  3. Proper fit: Regardless of the bike you ride, make sure it fits you. Take it to a bike shop and have a professional adjust your bike to you.
  4. Drink enough water: Jim loses about three pounds an hour during a ride. Make sure you rehydrate throughout the ride and at rest stops.
  5. Helmet: Always wear one!
  6. Know when to shift: It will make your riding easier.
  7. Get proper attire: Cycling shorts aren’t just nice, but necessary. Gloves can also act as a comfort measure; as well as protection should you fall off your bike.

The Ride to Conquer Cancer©

Join Penn Medicine’s Abramson Cancer Center (ACC) on October 11 to 12, 2014 in the Ride to Conquer Cancer© (RTCC)—an unforgettable and epic bike ride through Pennsylvania’s picturesque scenery -towards one life-changing destination: to cure cancer. The ride isn't just for cyclists, it's for anyone who wants to see a cure for cancer. 

At two-days and 150+ miles the RTCC will be a physical challenge—and an emotional and inspirational weekend—that will give you a chance to join forces with our physicians, patients, and families to leave everything on the bike course and raise serious funds and awareness in the ACC’s fight to cure cancer. 

The funds raised through the ride will be put to use immediately, powering the ACC's vision to eradicate cancer as a cause of human disease and suffering through precision medicine, novel research, next-generation therapies, and compassionate care. 

JOIN TODAY!

This event will be remarkable and will bring together communities of cancer survivors, cyclists, and their supporters with a common goal to conquer this disease. Join the ride in October by registering today at www.ridetovictory.org or by calling (844) 777-7433.

Before the ride, you will have access to:

  • Expert coaching
  • Training rides in your area
  • Personal web page for fundraising
  • Helpful manual
  • 2014 ride commemorative item

During the ride, participants will have access to:

  • Event-day ride jersey
  • Support along the route
  • Catered meals
  • Entertainment at camp
  • Massage and medical care

Childhood Cancer Survivor...and Annihilator

$
0
0
Shantae ‘Shani’ Ockimey has always taken on the role of protector. When she came out of the surgery that amputated her right leg after an osteoscarcoma diagnosis at 9, the first thing she asked was, “How is everybody?”

Now a childhood cancer survivor and a patient of The LIVESTRONG™ Survivorship Center of Excellence’s Living Well After Childhood Cancer™ Program (LWAC) at the Abramson Cancer Center—a collaborative effort between Penn Medicine and CHOP that tailors individual health care plans to manage the short and long-term medical and psychosocial effects of cancer treatment— Shantae’s concern for the wellbeing of others has only gotten stronger.

Shantae, age 10, while undergoing chemotherapy
 “When I was diagnosed,” Shantae relays, “I said I want to find a cure for cancer.”

As a Clinical Research Coordinator at the Children’s Hospital of Philadelphia (CHOP) she is helping do just that—moving science forward by facilitating patient clinical trials. By ushering brave individuals through trials, she is making the future better and brighter while providing hope for cures: all behind the scenes.

Shantae's personal cancer journey and involvement with LWAC exposed her to the many facets of health care, driving her professional involvement with finding a cure. Throughout high school and college Shantae worked on retrospective chart reviews and data analysis for Richard B. Womer, MD, attending physician at CHOP and professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania.

Dr. Womer, who specializes in sarcomas and medication and chemotherapy safety, was also Shantae’s childhood oncologist. Dr. Wormer and Shantae’s mentor in research Barbara Bayton, who was very instrumental in teaching Shantae how to coordinate clinical trials until her recent retirement, offered Shantae her first job out of college—and she has been at CHOP ever since.

Penn is leading the way in research that will benefit cancer survivors of all ages and types. Led by LIVESTRONG Survivorship Center of Excellence Program Director Linda A. Jacobs, PhD, RN, the Survivorship team consists of physician specialists, researchers, psychosocial and nutritional counselors, support services providers, a rehabilitation medicine physician, and an exercise physiologist.

“We empower patients to take control of their long-term health and well-being,” said Dr. Jacobs. “Our goal is to optimize patients’ quality of life. We are very successful in facilitating a very close relationship with oncologists and primary care doctors—so that new advances are immediately translated into the clinical environment.”

From doing research on such issues as bone loss, hot flashes, the impact of acupuncture, and lymphedema and cardiac problems that may develop following certain chemotherapy treatments, to helping patients cope with recurrence, genetics, insurance, and fertility issues, the LWAC provides survivors the tools they need to flourish after beating cancer.

Shantae (second to the right) with her sisters Janay, Tara, Tamara, and Dana and mom Carol (wearing scarf).
 And Shantae is doing just that. She is working towards a Master’s in Clinical Research, and plans on one day leading research projects at CHOP. As a patient of the LWAC Program at the Abramson Cancer Center, her care is no longer focused on cancer, but cancer’s long-term effect on her health.

“The Survivorship program has been source of guidance to the well being of my adult life after cancer. Dr. Jacobs and my team help me to think of my health in a long-term way, and deal with the adult issues resulting from surviving a childhood cancer,” Shantae explained. “I am so thankful it exists!” Because of her history, Shantae occasionally comes out from behind the scenes to speak with young patients with similar diagnosis to hers, or who are about to undergo an amputation, in order to help guide them.

“I remember the day of my surgery like it was yesterday. It is when I first cried over my diagnosis and when the magnitude of what was happening hit me,” Shantae recalled. “I love that I am able to use my life to help young people through similar experiences.”

She was also recently able to volunteer at Beyond Cancer, an annual event where families are able to reunite with fellow patients and staff.

“While everyone may not have had a personal cancer journey like mine that led them here, everyone appreciates the hardships that children and families go through with cancer,” Shantae explained of her co-workers.

“We are a tight knit group with a bond for one common goal: to help treat and cure cancers.”

The Living Well After Childhood Cancer™ Program is grateful for the generous support of the Rosato Family through the Sarah Marie Golf Invitational. The 11th annual golf outing will be held on September 29th at Sunnybrook Golf Club. Click here to learn more, attend, or support this important event.

To get more information about the survivorship program at Penn Call 1-800-789-PENN (7366) to be connected toll-free to our Living Well After Cancer™ Program.

Sara Gowing: A Partner in Hope Propels Research on Breast Cancer Recurrence

$
0
0
“I think that anyone who has received a cancer diagnosis would agree that it is a moment which is life-altering: emotions range from fear and sadness, to anger and regret, after which you can’t help but see everything in a different light.”

For Sara Gowing, that new light as a breast cancer survivor has been characterized by elation for her cancer remission and good health against the odds of and fear for her cancer returning.

“As my breast cancer treatment came to an end, I learned that palpation would be my primary method for monitoring recurrence,” Sara explained. “I was startled to think that after spending a year undergoing cutting edge treatments that included surgery, rounds of chemotherapy with two different drugs, and radiation, I would be back to relying upon breast exams to catch a recurrence of the cancer.”

Angela DeMichele, MD, MSCE (center) with Sara Gowing and her husband Jim, at the celebration of Dr. DeMichele's appointment as the Alan and Jill Miller Associate Professor in Breast Cancer Excellence.

Seeking an Active Measure for Recurrence in Post-treatment Survivorship

Despite 5-year survival rates approaching 90%, a substantial number of breast cancer patients relapse - and many more experience late treatment effects or are diagnosed with a second cancer. As a consequence, millions of breast cancer survivors find themselves in a post-treatment survivorship period that is largely devoid of active measures that they can take to monitor and prevent recurrence.

Sara asked her oncologist, and co-leader of the Breast Cancer Research Program, Angela DeMichele, MD, MSCE, what she could do to help propel breast cancer recurrence research forward.

“I got to know Dr. DeMichele particularly well during my chemotherapy. She was such a big help and provided so much reassurance during the unknowns surrounding my treatment,” Sara explained.

Forming the 2-PREVENT Translational Center of Excellence

“When I learned that the causes and treatment of recurrence was something that she was hoping to change through research, my husband and I were glad to be able to support this important work.”

The Gowings generously established the Breast Cancer Recurrence Program in support of the 2-PREVENT Translational Centers of Excellence (TCE) at the Abramson Cancer Center, co-led by Dr. DeMichele and Lewis Chodosh, MD, PhD, Professor and Chair of the Department of Cancer Biology, Perelman School of Medicine. Translational Centers of Excellence are virtual centers that bring the most brilliant minds across Penn’s medical campus together, to solve cancer’s most complex challenges.

The 2-PREVENT TCE focuses on the microscopic cells that are left in the body after cancer treatment—rather than the original tumor—and researches how they relate to the original tumor, where they live, how they grow and how they relate to the relapsed tumor. That information is then used to develop clinical trials focused on innovative, targeted therapies.

These cross-disciplinary teams are already making great progress, helping deliver novel, personalized cancer care to cancer patients.

Sara has joined the ranks of the Abramson Cancer Center’s brave patients, advocates, and philanthropists who have formed a community of support in the fight to advance research that offers better options and therapies for women diagnosed with breast cancer.

“I am so pleased to be able to support the amazing work being done at the Abramson Cancer Center and know that we will be able to find a cure for breast cancer. Forever.”

For more information on how to support breast cancer recurrence research please contact Laura Ferraiolo at lferr@exchange.upenn.edu or by phone (215) 746-2948, or make a gift online.

Supporting Prostate Cancer Research and Inspiring the Next Generation of Philanthropists

$
0
0
The power and importance of philanthropy is an essential concept to instill in the next generation. As the Vozar family demonstrates, it is often a lesson best passed on from father to son. In May, Jim Vozar and his son, JT, participated in the TD Five Boro Bike Tour—America’s largest cycling event, with over 32,000 riders—to raise support for prostate cancer research at the Abramson Cancer Center.

Jim is the Director of Business Development at ARCO Design/Build, Inc., a national construction company, and JT is entering the 8th grade. Jim had become struck by the prevalence of prostate cancer, which affects 1 in 6 men in America, and the need for research funding. After doing his own research on prostate cancer programs in the region, he was impressed by the Abramson Cancer Center’s reputation for top-notch prostate cancer research and patient care and its focus on research initiatives that can have transformative impacts on prostate cancer treatments.

So, Jim and JT raised support from friends and family and joined a group of like-minded cyclists, making their way through the five boroughs of New York City. Jim and JT not only had a fantastic day together touring New York City by bike, but they raised funds for the important work being done at Penn. And Jim was able to demonstrate to his son the importance of giving back to a worthy cause.

Jim and JT plan to make philanthropy a tradition by participating in the event again next year, continuing their positive impact on prostate cancer research at Penn.

If you are interested in supporting prostate cancer research and clinical care at the Abramson Cancer Center, or if you would like to learn more about the program, please contact Andrew Bellet at 215-573-0548 or abellet@upenn.edu. To make a gift to support prostate cancer research, please visit www.pennmedicine.org/prostatefund.

Dancing Sparks a Commitment to a Cancer Cure

$
0
0
The McNichol Family, from left to right: Joseph, Nancy, Katie, Patrick, 
Jared Ingersoll, Charlie Ingersoll, and Leigh Ann Ingersoll.
When Patrick McNichol signed up to participate in THON—Penn State’s year-long student run fundraiser that culminates with a forty-eight hour dance marathon in support of pediatric cancer patients, family, research—as a senior, he unwittingly set a course for a life committed to philanthropy.

“I got involved with THON a little late in my college career, and felt that I could have done more,” Patrick said. “The summer after graduation, a few friends and I started a fundraiser down the shore in Avalon, NJ called War on the Shore.”

War on the Shore, which supports The Four Diamonds Fund, just held its 10th annual event—and has successfully raised over $250,000 since 2004.

Capitalizing on their common goal of building a strong philanthropic network in support of cancer research and care the group, consisting of Vice President Erik T. Christian, Secretary James D. Krugh, and Treasurer Corey M. Talone, started the Elpis Foundation. Named after the Greek goddess of hope who was the last deity to be released from Pandora’s Box, Elpis personifies the promise of a world without despair

And that is the Elpis Foundation’s intention: to build a community that inspires hope, raises awareness, and offers unwavering emotional and financial support for cancer research, treatments, and care.

“War on the Shore expanded into other events, golf outings and bowling tournaments that support different cancer research,” Patrick said. “This isn’t our day job—we keep Elpis going in our free time, and are motivated by our shared vision of world without cancer.”

One Father’s Fight Inspires a New Era of Hope

But in September 2011, Patrick’s connection to cancer became deeply personal. His father, Joseph F. McNichol, was diagnosed with Stage IV, non-small cell lung cancer— sadly losing his battle only a year later, in July 2012.

The McNichol Family
 “Lung cancer is incredibly hard to detect and diagnosis often comes too late. It kills more people than breast, prostate, and colon cancers combined yet continues to be one of the lowest funded forms of cancer in terms of research and treatment,” Patrick explained. “There is such a negative stigma as well, that people deserve it, when some of the worst lung cancers are not caused by tobacco use.”

The Elpis Foundation wants to change that – and in February 2013 held its inaugural JFM Memorial Gala to honor his father’s life, the treatment he received at Abramson Cancer Center of the University of Pennsylvania by Charles B. Simone II, MD, and to inspire hope.

The Elpis Foundation pledged $200,000 to the Abramson Cancer Center, establishing the Joseph F. McNichol (JFM) Lung Cancer Research Fund to support the advancement of lung cancer research and awareness through Penn’s Interdisciplinary Thoracic Oncology Program, specifically as it relates to early detection and screening, treatment, and advances in radiation oncology.

Why Penn Medicine

Penn Medicine’s Thoracic Oncology Program is one of the few centers in the world that is able to offer a full spectrum of personalized treatment options that aren’t available everyone else.

“We are at the cutting edge technology for radiation therapy, revolutionary discoveries in the lab, translational research in the clinic, surgical options, and world-class pulmonologists,” says Dr. Simone, Assistant Professor of Radiation Oncology who specializes in lung cancer, mesothelioma, and other thoracic malignancies. “We are uniquely able to handle encompassing expertise across the care modalities.”

Early detection is critical, and to this end, the JFM Fund supports research of circulating tumor cells (CTCs) — the cells shed from primary tumors or their metastases that circulate in the bloodstream. CTCs hold information researchers at the Abramson Cancer Center believe could be a lynchpin to a better understanding of cancer diagnosis, metastases, and recurrence. Unlocking the potential within CTCs opens up the possibility for a “liquid biopsy,” a non-invasive blood test that will provide live information about the patient’s disease status, and a roadmap to personalized targeted cancer therapies.

“Beyond the amazing, compassionate care my father received at the Abramson Cancer Center, the more we learned about the disease during his treatment, the more we knew this was the place for the Elpis Foundation to direct much needed resources to lung cancer research and care,” said Mr. McNichol.

To make a gift to lung cancer research, click here or contact Natalie Reznik at nreznik@exchange.upenn.edu or (215) 746-3009.

Celebrating the Human Connection: An Endowed Chair for Michael D. “Dr. Mike” Cirigliano

$
0
0
A wide array of Penn Medicine leadership, faculty, patients and staff gathered November 5th at the Smilow Center for Translational Research to honor a man widely lauded for his humanistic approach to medicine. Michael D. “Dr. Mike” Cirigliano, MD, FACP, was named the inaugural chair holder of the Founders Associate Professorship in General Internal Medicine. When Dr. Cirigliano retires, the Professorship will bear his name in perpetuity.

At the professorship celebration honoring “Dr. Mike”: (left) Ed Snider, Dr. Michael D. Cirigliano, Dean J. Larry Jameson

Dr. Cirigliano is a 1990 graduate of the Perelman School of Medicine and also completed his internship and residencies at Penn. In addition to his internal medicine practice, “Dr. Mike” is a popular medical commentator on television’s Fox 29 in Philadelphia.

Speaking at the professorship celebration, Spectacor chair Ed Snider called Dr. Cirigliano “one of the greatest human beings I have ever met.” Snider detailed how the internist saved his life through aggressive testing that uncovered an early, treatable cancer. “I’m cured, thanks to this man,” said Snider. “And I know I’m not the only one,” he added. Snider and his wife Lin were among the lead donors for the endowed chair, in addition to Tom and Linda Knox, Aileen and Brian Roberts, the Biesecker family and Laddie and Linda Montague.

Perelman School of Medicine Dean J. Larry Jameson commented on the challenging field of internal medicine, declaring that good internists such as Dr. Cirigliano “need to know a little bit about every disease.” Dean Jameson also lightheartedly paid tribute to “Dr. Mike’s” television popularity, noting that, “Like Cher, Madonna and Dr. Ruth, you’re really special when you are known by just your first name.”

University of Pennsylvania Health System CEO Ralph Muller stated that while Penn Medicine is an institution firmly grounded in science, it remains critically important to honor the person- to-person experience. Dr. Cirigliano, Muller said, “is a prime example of our tradition of listening to our patients.” Michael Parmacek, MD, the chair of Penn’s Department of Medicine, remarked on Dr. Cirigliano’s multiple awards for his teaching, and how he continually advocates for a greater emphasis of patient-focused policies throughout Penn Medicine.

Dr. Cirigliano said that he tries to create a Norman Rockwell-type experience for his patients throughout their medical journeys. “For me, it’s all about the human connection. I’m well aware that every day, I live on the doorstep to eternity.”

Engaging Alumni in the Drive Toward 250

$
0
0
Dean Jameson opened the fall meeting of the Medical Alumni Advisory Council (MAAC) by reflecting on the immediate and enduring impact of the medical school on regional, national, and global medicine.

Examples abound, providing multiple points of pride that encourage alumni involvement. The dean started at the beginning with founding professor and physician-in-chief of the Continental Army, John Morgan, MD, C’1757.

Dr. Howard Eisen (left) as John Morgan, with His Excellency
General George Washington
“Dr. Morgan connects our School to the founding of the country,” said MAAC member Howard Eisen, M’81, shown here as John Morgan in last December’s reenactment of Washington’s crossing of the Delaware River. “It’s truly remarkable that our School has been involved in such critical moments.”

Dean Jameson highlighted the School’s Nobel and Lasker Award winners, and the ongoing impact of today’s faculty members, such as Carl June, MD, Jean Bennett, MD, PhD, Garret FitzGerald, MD, Katherine High, MD, Jeffrey Drebin, MD, PhD, and Daniel Rader, MD. The dean also noted Penn Medicine’s increasing role in providing leading-edge health care for the region, calling attention to the multidisciplinary facilities in Valley Forge and Radnor, the recent opening of Penn Medicine University City, and the new space above the Jordan Medical Education Center that will house the Center for Advanced Cellular Therapeutics (CACT).

As the January 2015 opening of the Henry A. Jordan M’62 Medical Education Center approaches, Senior Vice Dean for Education Gail Morrison, M’71, FEL’76, thanked alumni for making it happen and recognized recent alumni contributions:

Joseph Zebrowitz, C’88, WG’06, and Lauren Wylonis, RES’98, for naming the Center for Student Activities
Louis Matis, M’75, for naming a seminar room
Barry Gertz, C’73, GR’79, M’79, INT’82, for naming a quiet study lounge.

The City View Patio, East Pavilion Event Space and Dais, and mezzanine conference rooms are among the naming opportunities still available in the Jordan Medical Education Center.

One of Penn’s most successful global projects, the Botswana-UPenn Partnership, celebrates its 10th anniversary in October. Harvey Friedman, MD, FEL’75, HOM’81, provided an overview of the program, which has helped to establish over 32 antiretroviral treatment sites where none existed as recently as 2008. This program also annually attracts a significant number of Perelman students committed to global health. Country Director Doreen Ramogola-Masire added to the presentation by highlighting the benefits of mobile health and telemedicine in the success of the partnership in which the Ministry of Health has also played a key role.

Looking ahead, Robert Smith, M’16, and Kay Negishi, M’15, student representatives of the Perelman School of Medicine Houses, and master clinician E. Cabrina Campbell, RES’93, representing the Wood House, described the Perelman School’s recently enacted house system. These virtual associations encourage social interaction and mentorship between classes, and organize all current medical students into four houses named after four Perelman School luminaries: John Morgan; Helen O. Dickens, GM’45, HON’82; Jonathan E. Rhoads, GRM’40, HON’60; and Francis C. Wood, M’26, INT’30, HON’71.

MAAC Chair Lou Kozloff, C’65, M’69, closed the proceedings with the call to further engage alumni at what couldn’t be a better time – celebrating 250 years and a sparkling future.

Turning 250: Q&A with Jonathan Epstein, MD

$
0
0
“Penn is special, and unusual, in that we are among the best at what we do, and we’re also friendly and encouraging. Often in academic medicine, these are mutually exclusive, but at Penn, they go together.”

Jonathan A. Epstein, MD, William Wikoff Smith Professor of Cardiovascular Research and chair of the Department of Cell and Developmental Biology, offers his thoughts on the Perelman School’s significant birthday.

Q: You have been with Penn Medicine since 1996. What makes you most proud about your career here?

A: I’m most proud to be part of a faculty with such rapidly growing impact on the international stage. During my time at Penn, the trajectory has been unbelievable, and it’s so exciting to see new knowledge transformed into new cures.

In my own lab, discoveries we’ve made in basic science and in model organisms through the last 10 years are finding their way to the clinic. It’s very exciting to be setting up clinical trials to test some of our theories about heart failure. Specifically, we’ve proposed some chemicals and drugs that might be beneficial for patients who have had heart attacks, and we are now in a position to test them in patients.

Q: What stands out among your experiences at Penn?

A: The people. For whatever reason when I set about my career, I didn’t expect that my colleagues would also be among my best friends. But it didn’t take me long to see that the faculty here is welcoming, interactive, and scientifically challenging. I enjoy working with so many of my colleagues – it makes coming to work fun.

One example out of many: Mike Parmacek, MD, former Chief of Cardiology and current Chair of the Department of Medicine, for instance, has been a terrific friend and longtime collaborator. We share scientific interests about how the heart and vasculature develop and function. As important, though, is what Mike has taught me about leadership. His straightforward, honest approach with people has been a source of inspiration, and he’s been a great friend.

Q: Who are some of your key collaborators?

A: Within the Penn Cardiovascular Institute, I’ve worked closely with Dan Rader, MD, one of the most productive and well-respected cardiologists and researchers in the nation. He has a particular interest in lipids, and our work has been very complementary. I’ve also worked very closely with Ed Morrisey, PhD. He is the Scientific Director of the Institute for Regenerative Medicine and one of the leading experts in both heart and lung formation. Ed has been a leader at Penn with regard to new research technologies and approaches, and we have had a number of productive collaborations and large multi-investigator research grants together.

I’ve also worked with Ken Zaret, PhD, and Shelley Berger, PhD, and I am proud to say I helped to recruit them to Penn. They have built an extremely influential program in epigenetics, a cutting-edge area of research that is impacting every realm of medical therapy.

Q: What would make a good birthday present for the Perelman School?

A: An endowment that allows our students to pursue their dreams without worrying about financial support.

And for those who are here when it’s time to celebrate the 300th anniversary, my wish is that things are as good for them as they are for us right now. I hope that they will have continued the traditions of collaboration and collegiality that make science and health care fun for the people who work here and that make us among the very best in the world.

Viewing all 85 articles
Browse latest View live